Avenue Supermarts Limited — Others, 11-01-2025: Change in Management

The company has announced a board meeting where it appointed Mr. Anshul Asawa as Chief Executive Officer Designate, effective from 15th March 2025, succeeding Mr. Ignatius Navil Noronha, who will complete his term on 31st January 2026. Additionally, Mr. Hitesh Shah has been appointed as Head-Pharma Business and Mr. Rajeev Chandrasekharan as Head-Centre of Excellence, both effective immediately. Mr. Ashutosh Dhar's role has changed, and he will no longer be considered part of the Senior Management Personnel.

This leadership transition positions the company for future growth, leveraging Mr. Asawa's extensive experience in product category development from his tenure at Unilever. It may enhance investor sentiment by presenting a continuous commitment to strong management and operational efficiency in core areas, though investor focus may also shift to how well the new appointees adapt to their roles.